Rhoen Klinikum AG (XTER:RHK) 3-Year EBITDA Growth Rate : 13.00% (As of Dec. 2023)

View and export this data going back to 1989. Start your Free Trial

What is Rhoen Klinikum AG 3-Year EBITDA Growth Rate?

Rhoen Klinikum AG's EBITDA per Share for the three months ended in Dec. 2023 was €0.54.

During the past 12 months, Rhoen Klinikum AG's average EBITDA Per Share Growth Rate was 9.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 13.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -1.80% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -9.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Rhoen Klinikum AG was 60.20% per year. The lowest was -48.90% per year. And the median was -4.70% per year.

Competitive Comparison of Rhoen Klinikum AG's 3-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, Rhoen Klinikum AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rhoen Klinikum AG's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Rhoen Klinikum AG's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Rhoen Klinikum AG's 3-Year EBITDA Growth Rate falls into.

Rhoen Klinikum AG 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Rhoen Klinikum AG (XTER:RHK) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Rhoen Klinikum AG 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Rhoen Klinikum AG's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhoen Klinikum AG (XTER:RHK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Rhoen Klinikum AG (XTER:RHK) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

RKAGY:USA RHKJF:USA 0NQH:UK RHK:Austria

Address

Salzburger Leite 1, Bad Neustadt a. d. Saale, DEU, 97616

Website

https://www.rhoen-klinikum-ag.com

Rhoen Klinikum AG provides medical care focused in five key areas: cardiovascular medicine, neuromedicine, oncology, pulmonary diseases, and orthopedic and trauma surgery. The firm operates in three business areas: acute hospitals, medical care centers, and rehabilitation hospitals. The acute hospitals business contributes to the vast majority of the firm's overall revenue. The majority of patients at the firm's acute hospitals and medical care centers are treated on an outpatient basis. Rhoen Klinikum generates the entirety of its revenue in Germany, with the Bavaria and Hesse regions contributing the largest proportions of revenue.

Rhoen Klinikum AG (XTER:RHK) Headlines

No Headlines